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CHAPTER I

INTRODUCTION

Clinically patients who are chronically hyperthyroid experience an increased heart
rate, stroke volume, systolic blood pressure, cardiac output and cardiac contractility along
with various atrial irregularities including atrial fibrillation (Klein & Ojamaa, 1994;
Ridgeway, 1994; Natazawa et al., 1994). Most of the laboratory research to date has been
conducted on ventricular tissue investigating the chronic effects of thyroid hormone
exposure, that are mediated by nuclear receptors, leading to alterations in specific gene
expression (Polikar et al., 1993; Sap et al., 1986; Franklyn & Gammage, 1996;
Oppenheimer et al., Samuels & Tsai, 1973). Various researchers have documented an
increase in cardiac contractility (Buccino et al., 1967; Howitt et al., 1968) and a decrease
in action potential duration (Freedberg et al., 1970) due to alterations in ion channel
properties and contractile protein mRNA synthesis/degradation rates (Johnson et al.,
1973; Sharp et al., 1985; Franklyn & Gammage, 1996; Meo et al., 1994; Binah et al.,
1987; Meo et al., 1995; Ojamaa et al., 1992). The slow inward current (I 5J (Rubinstein
& Binah, 1989), the outward rectifying current (IJ (Rubinstein & Binah, 1989) and the

Ca2+ current OcJ (Binah et al., 1987) all increased with chronic 1; exposure. Cardiac
contractile proteins (a.- &

P- MHC) mRNA levels as well as associated excitation1

2

contraction regulatory proteins (SR Ca2+ -A TPase, phospholambam, and ryanodine
receptors) mRNA synthesis/degradation rates varied with chronic T3 exposure. While

P-

MHC mRNA decreased with chronic T3 exposure (Franklyn & Gammage, 1996; Balkman

et al., 1992), a-MHC mRNA increased (Ojamaa et al., 1992; Franklyn & Gammage,
1996; Balkman et al., 1992). SR Ca2+-ATPase (Ojamaa et al., 1992; Arai et al., 1991)
and ryanodine receptor mRNA increased (Arai et al., 1991) whereas phospholambam
mRNA decreased (Seitz et al., 1994) with chronic T3 exposure leading to faster cellular
contraction rate and an increased rate of cellular relaxation due to increased Ca2+ SR reuptake.
Only recently have the acute effects of thyroid hormone exposure been
investigated. Initially there was controversy about whether the effects seen after a brief
bout of T3 exposure were in fact due to different mechanisms from the nuclear mediated
effects. Now there is documented proof of plasma membrane T3 receptors (Segal, 1989).
Previously there has been documented increases in the Na+ current in neonatal cardiac
myocytes (Harris et al., 1991) and rat ventricular myocytes (Dudley & Baumgarten, 1993)
and increases in the cellular Ca2+ uptake in rat heart slices (Segal, 1990) and the isolated
perfused heart (G0tzsche, 1994) with acute T3 exposure. Little is known, however, about
the acute effects ofT3 on atrial muscle cells from the adult heart. It is not known whether
the previously documented chronic effects altering cardiac contractility and conduction
irregularities are attributable to changes seen during an acute exposure to T 3• With
previous documented effects of acute T 3 exposure affecting Na+ current (Harris et al.,
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1991; Dudley & Baumgarten, 1993) and cellular Ca2+ uptake (Segal, 1990; Gmzsche,
1994 ), the present research was conducted to investigate the acute effects of thyroid
hormone on atrial muscle cells. These experiments will investigate whether the acute
effects ofT3 exposure are similar to the previously documented chronic effects on cardiac
function. Results from this research will provide a greater understanding of the cellular
mechanisms present during hyperthyroidism and lead to an understanding of potential
arrhythmogenic and therapeutic effects of acute thyroid hormone replacement.

CHAPTER II

LITERATURE REVIEW

A. Synthesis of Thyroid Hormone
T4ff3 production in the thyroid gland. The thyroid gland is the source of two

major hormones, tetraiodothyronine (T4) and triiodothyronine (T3). T3 is considered the
biologically active thyroid hormone due to its 10 fold higher affinity for the nuclear
thyroid hormone receptor (Berne & Levy, 1993). The synthesis of thyroid hormone
occurs within the thyroid gland on thyroglobulin. Within the follicle, thyroglobulin is
iodinated to yield both monoiodotyrosine (MIT) and diiodotyrosine (DIT) with coupling
of mono and diiodotyrosine moieties to form T4 (DIT + DIT) or T3 (DIT+ MIT) (Genuth,
1993). Secreted from the thyroid gland, thyroxine (T4) constitutes approximately 85-90%
of the output with T3 comprising about 10-15 % and reverse T3 (rT3) accounting for only
1%(Sypniewski,1993; Genuth, 1993). The half lives ofT4 and T3 are 7 and 1.5 days
respectively (Sypniewski, 1993). The majority of T3 available to the body tissue is
derived outside of the thyroid gland from the peripheral conversion of T4 to T3 by the
5'-monodeiodinase enzyme located primarily in the liver and kidney (Astwood, 1970).
Cellular thyroid hormone uptake. Once released into the blood stream, T4 and

T3 are primarily bound to the blood proteins thyroid-binding globulin, thyroid-binding
4
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Figure 1
Thyroid Hormone Chemical Structures
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Thyroid hormone chemical structures.
(modified from Goodman & Gilman, 1970)
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prealbumin, and albumin with only 0.02-0.03% and 0.2-0.3% respectively representing
the biologically active free form (Sypniewski, 1993; Genuth, 1993; Astwood, 1970). Two
theories of cellular thyroid hormone uptake have been presented. Originally, Lein and
Dowben ( 1991) offered indications that triiodothyronine uptake into the tissue occurred
as simple diffusion, which seemed to correlated well with the lipophilic properties of
thyroid hormone. Recent research in thyroid hormone uptake provides evidence that there
is a saturable, stereospecific, energy dependent processes which is responsible for T3
uptake in rat skeletal muscle (Pontecorvi & Robbins, 1986). Oppenheimer & Schwartz
(1985) provide further evidence of a stereospecific transport of thyroid hormone into the
nucleus due to the preferential accumulation of L-T3 versus D-T3 in the intact animal.
Once in contact with the nuclear or plasma membrane receptors, thyroid hormone
is able to influence the cell leading to changes in the metabolic, mechanic and
electrophysiologic properties.

B. Clinical Effects of Hyperthyroidism
The biological hallmark of abnormal thyroid function is a change in the basal
metabolic rate (Klein, 1990). Thyroid hormone acts primarily to stimulate cellular
oxygen consumption and substrate utilization (Muller et al., 1994). Hyperthyroidism is
characterized by elevated serum levels of T 3 and T4 , due to either an overproduction of
T3 and T4 in the thyroid gland, an increased release of thyroid hormone from the thyroid
gland or an exogenous administration of thyroid hormone. The pharmacological actions
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of thyroid hormone include alterations in cardiovascular function and in metabolism of
glucose, fatty acid and protein. Hyperthyroidism has been documented to produce a
positive cardiac inotropic as well as chronotropic effect with potential arrhythmogenic
effects, such as atrial fibrillation (Ridgeway, 1994; Ito et al., 1994). Cardiovascular
actions of T3 can be attributed to (1) direct effects upon the heart, (2) effects upon the
peripheral circulatory system, or (3) interactions with the sympathetic/adrenergic system
(Nicod et al., 1993). Cardiovascular manifestations of a sustained elevation in thyroid
hormone levels include an increased heart rate, myocardial contractility, stroke volume,
systolic blood pressure, cardiac output, a widened pulse pressure and a decreased diastolic
blood pressure (Klein & Ojamaa, 1994). Contributing to these cardiovascular affects of
T 3 are alterations in ion channel properties and associated contractile protein
synthesis/degradation rates.
Mechanic. Mechanically, when the heart is placed under a hyperthyroid condition
contractility increases. Buccino et al. (1967), using cat papillary muscles, found a more
rapid rate of tension development with less time to reach peak tension in the muscles from
chronic hyperthyroid animals, though the maximum tension developed was not
significantly greater than from euthyroid animals. Howitt et al. (1968), reported indirect
indices of increased contractility in humans by showing a shorter ejection time and
increased mean systolic ejection rate, suggesting that ejection velocity was enhanced.
Electrophysiologic. Hyperthyroidism effects the electrophysiology of the heart
by altering various ionic currents which underlie the generation of the action potential at
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the single cell level, effecting the conduction and eventual contractile behavior of the
heart organ. Tachycardia associated with hyperthyroidism has been shown to be due to
a combination of a decrease in action potential duration coupled with an increased rate
of diastolic depolarization in the sinoatrial node pacemaker cells (Marshall, 1973 ).
Freedberg et al. (1970), using isolated atria from rabbits, showed that although the resting
membrane potential and the height of the action potential did not differ, the duration of
the action potential repolarization was shortened in animals who received T4 for 6 weeks.
In hyperthyroid dogs, A-V functional refractory period and conduction time were both
significantly shortened as the A-H interval decreased with no change in H-V interval
(Goel, 1972).

Hemodynamic. Hemodynamically, hyperthyroidism places altered preload and
afterload forces upon the heart muscles. Thyroid hormone has been shown to lead to
peripheral vasculature relaxation (Klein et al., 1994; Dillman, 1989) with decreased
circulation time (Smallridge, 1980). This relaxation was due to the direct effect of thyroid
hormone on vascular smooth muscle, without influence from endothelium-derived
relaxing factor(s), a- or

P-

receptor activation, or muscarinic cholinergic receptor

activation (Hidaka et al., 1989). An increased blood volume (Klein, 1994), cardiac filling
(Dillman, 1994), stroke volume, heart rate, coronary blood flow and oxygen consumption
were also present during hyperthyroidism (Smallridge, 1980).

Metabolic. Sustained elevated thyroid hormone levels have been shown to effect
intermediary metabolism, stimulating oxygen consumption and oxidation of glucose, fatty
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acids and amino acids. Mitochondrial adenine nucleotide translocase proteins and
respiratory chain enzymes increased under hyperthyroid conditions in the liver. Glucose
metabolism increased with thyroid hormone due to an increased amino acid uptake by the
liver, an increased activity of gluconeogenic enzymes and an increased oxygen
consumption leading to an increase in ATP supply for many metabolic pathways
including glucose production. In liver, fatty acid oxidation CP-oxidation) and ketone body
production increased with thyroid hormone. Hyperthyroidism is usually accompanied by
a negative nitrogen balance with muscle wasting being an obvious sign but surprisingly
heart muscle protein did not decrease but actually increased, due to the multiple factors
placed upon the heart muscle under elevated thyroid hormone levels (Seitz et al., 1994).
Due to the clinical manifestations of hyperthyroidism, such as tachycardia,
nervousness, and tremors, mimicking a hyperadrenergic state, researchers have
investigated whether the response to thyroid hormone resulted from a stimulation of the
sympathetic nervous system (Polikar et al., 1993 ). Plasma levels of catecholamines were
normal or low in hyperthyroidism (Coulombe et al., 1976). Williams et al. (1977)
reported in rats that chronic administration of thyroid hormone up regulated the number
of P-adrenergic receptors leading to an increased cardiac catecholamine sensitivity.
Therefore the hyperadrenergic state seen in hyperthyroidism suggest a hypersensitivity
to catecholamines rather than an increase in sympathetic activity, because plasma
catecholamine levels are normal or decreased during hyperthyroidism.
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c. Cellular Effects of Hyperthyroidism-Chronic
Nuclear Receptor Binding. At the cellular level, it is well recognized that the
biologically active thyroid hormone (T3) exerts its action by binding to specific thyroid
hormone receptors, a protein product of the cellular erythroblastosis A (c-erb A)
supergene family, located on the nuclear membrane (Franklyn & Gammage, 1996; Polikar

et al., 1993; Sap et al., 1986; Oppenheimer et al., 1972; Samuels & Tsai, 1973).
Researchers have discovered binding sites for thyroid hormone on nuclei isolated from
atrial and ventricular cardiac muscle (Banerjee et al., 1988), and on liver and kidney
tissue (Oppenheimer et al., 1972). Upon thyroid hormone binding to its nuclear receptor
with subsequent receptor binding to various enhancer/promoter sequences on DNA, gene
transcription is stimulated or inhibited (Franklyn & Gammage, 1996; Polikar et al., 1993;
Sap et al., 1986). Changes in the quantity or properties of such proteins that are important
in the modulation of cardiac contraction may underlie the contractile changes that
accompany hyperthyroidism.

Contractile Associated Proteins. It has been shown in rat heart that chronic T3
exposure induces synthesis of a-myosin heavy chain (MHC) mRNA while exerting an
inhibitory effect on P-MHC synthesis (Franklyn & Gammage, 1996), leading to an
increase in myosin V 1 and a decrease in myosin

\'3

isoenzymes (Dillman, 1990). In a

time course experiment, Balkman et al. (1992) showed that hypothyroid rats increased aMHC mRNA over time, eventually reaching 93% ± 1% of total MHC mRNA, coupled
with a decrease in the P-MHC mRNA levels. Myosin V 1, composed of 2 MHC a
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subunits, has a higher myosin ATPase activity than myosin V3 , which contains 2 MHC

p subunits.

The globular head of myosin V 1 with its higher myosin A TPase activity than

myosin V3 resulted in an increased velocity of contraction (Dillman, 1990). This marked
thyroid hormone-induced change in myosin isoenzyme predominance was demonstrated
in small animals (rats, rabbits) but did not occur to a similar extent in larger species,
including the human heart in which V 3 is the major ventricular isoenzyme (Franklyn &
Gammage, 1996).
In rabbit skeletal and cardiac muscle chronic T 3 administration increased the
steady state levels of cardiac ryanodine receptor mRNA and SR Ca2+ -ATPase mRNA
when compared with euthyroid rabbit (Arai et al., 1991 ). The SR Ca2+ -ATPase functions
to regulate the intracellular calcium concentration of the myocyte and therefore affects the
rate of Ca2+ release and uptake, affecting the rate of systolic tension development and the
diastolic relaxation time (Arai et al., 1991 ). Ojamaa et al. (1992) demonstrated in a
heterotropic isografted rat heart that although thyroid hormone required an increased
hemodynamic load to increase cardiac protein synthesis, thyroid hormone altered the
expression of a-MHC and SR Ca2+ -ATPase mRNA concentration, increasing them 181
and 208% versus euthyroid animals respectively. SR Ca2+ -ATPase mRNA which had
been depressed in hypothyroid when compared with euthyroid rat hearts, responded to T4
with elevated SR Ca2+ -ATPase mRNA levels reaching 255% of control after 72 hours
(Balkman et al., 1992).
Phospholambam, a SR Ca2+ -ATPase regulatory protein, mRNA was decreased in
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both hyperthyroidism and hypothyroidism while calsequestrin mRNA levels exhibited no
change with thyroid status, indicating that thyroid hormone does not alter the calcium
storage capacity to the SR (Seitz et al., 1994). T3 also has been shown to increase
production of mRNA encoding for Na-K ATPase, which is responsible for restoring the
Na/K gradients and membrane potential after excitation (Evert, 1996).
In a developmental study, rat ventricular myocyte Tnl mRNA levels were higher
in euthyroid versus hypothyroid. Upon addition of T3 to young rats (<28 days) Tnl
mRNA increased versus control, but the effect was not seen after 87 days of gestation,
suggesting that the level of Tnl mRNA was more sensitive to thyroid status in younger
rats (MacKinnon & Morgan, 1986). Other studies provide further evidence for specific
mRNAs being induced by T3 in a highly tissue specific manner (Shanker et al., 1987).
Ionic Currents. Chronic T3 exposure also effects various ionic currents in cardiac

and skeletal muscle. Hyperthyroidism increased the slow inward current {1 5J, shifting the
threshold for activation as well as the peak current to more negative potentials when
compared with control, while hypothyroidism decreased the Isi current (Rubinstein &
Binah, 1989). The outward rectifying current (IJ increased with chronic T3 exposure but
hypothyroidism had little effect on IK (Rubinstein & Binah, 1989). The peak calcium
current also increased in hyperthyroid ventricular myocytes (Binah et al., 1987).
Hypothyroidism, in rat ventricular myocytes, decreased the transient outward potassium
current {1 55) while hyperthyroidism increased the amplitude of J55 (Shimoni & Severson,
1996).
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Cardiac Inotropic Response. Incorporating the ionic current and contractile
protein alterations with T3, the effect of thyroid hormone on cardiac function has been
demonstrated on action potential and cardiac contractile mechanics. T3 exhibited positive
inotropic characteristics leading to a decrease in action potential duration (Johnson et al.,
1973; Meo et al., 1994;Binah et al., 1987; Meo et al., 1995) and a decrease in the time to
peak tension development (Sharp et al., 1985). In rat ventricular myocytes, heart rate
increased as well as the ventricle displayed a faster rate of contraction and relaxation
leading to a shortened contraction cycle when compared with euthyroid myocytes. There
was no change in maximum tension developed by the ventricle, but the duration of the
contraction was shorter. This study concurrently measured the calcium transient which
was shorter in duration with T3 and the rise and decline of the calcium transient which
exhibited faster kinetics than in euthyroid cells (MacKinnon & Morgan, 1986).
Vascular Smooth Muscle. Thyroid hormone directly effected vascular smooth
muscle, leading to vascular relaxation in the presence of the P-receptor blocking drug
propranolol, the a-receptor blocker phentolamine and the muscarinic cholinergic blocking
agent atropine. Endothelium-derived relaxing factor(s) could also be ruled out as the
mechanism of thyroid hormone induced vascular relaxation as thyroid hormone displayed
its effect on tissue in which the endothelium was intact or removed (Ishikawa et al.,
1989).
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D. Cellular Effects of Hyperthyroidism- Acute
Plasma Membrane Mediated Actions. In the last couple of decades the acute
effects of thyroid hormone on skeletal, smooth and cardiac muscle have been investigated.
Focus has turned to the possible plasma membrane-mediated effects of thyroid hormone,
apart from the documented nuclear membrane-mediated effects seen with chronic thyroid
hormone exposure. Characteristically, the plasma membrane-mediated effects of thyroid
hormone are prompt in onset (seconds to minutes), independent of new protein synthesis,
and are associated with changes in the transmembrane transport of ions and substrates
(Segal, 1989). Extranuclear sarcolemmal effects of thyroid hormone include effects on
the inward rectifier potassium current (Sakaguchi et al., 1996), the sodium current (Harris

et al., 1991; Dudley & Baumgarten, 1993), sugar (2-deoxyglucose) transport (Segal &
Ing bar, 1990; Segal, 1989), Ca2+-ATPase (calcium pump) activity (Segal et al., 1989;
Davis et al., 1983), and calcium release from ryanodine receptors (Connelly et al., 1994).
Also shown during acute thyroid hormone infusion has been an effect on cardiac
conduction time (Gmzsche, 1994), contractility (Gmzsche, 1994; Ririe et al., 1995), and
cardiac output (Gmzsche, 1994). In addition to the plasma membrane mediated actions
of acute thyroid hormone exposure, thyroid hormone has been shown to promote
extranuclear effects on some cytosol proteins (protein kinases) (Lawerence et al., 1989)
and on SR Ca2+-ATPase activity (Warnick et al., 1988).

Ionic Currents. Ionic currents that modulate various cardiac functions have been
investigated during acute thyroid hormone exposure. In ventricular guinea pig myocytes,
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Sakaguchi et al. ( 1996) demonstrated an increase in the inward rectifier potassium current
(IK 1) with 1 nM T 3• At the single channel level thyroid hormone application increased the
mean open time (P0 ) of the inward rectifier potassium channel (I Kl ) due mainly to a
decreased interburst duration, with no change in the single channel amplitude or slope
conductance. It is known that IK 1 is the main contributor to the late phase of action
potential repolarization (Ibarra et al., 1991 ). Therefore, these researchers suggested that
thyroid hormone may shorten the action potential duration by enhancement of IK 1
(Sakaguchi et al., 1996).
Dudley and Baumgarten ( 1993) have investigated the effects of acute exposure of
thyroid hormone on cardiac sodium channels in rat ventricular myocytes, showing that
T 3 ( 5 or 50 nM) induced an increase in the bursting behavior of the channel without a
change in the unitary conductance. Using TAA, which does not bind to nuclear thyroid
hormone receptors (De Nayer, 1989), bursting behavior increased similarly to T3 ,
indicating that with in the experimental time frame T3 was not mediating its effects
through nuclear receptors. They further reported that T3 only increased channel bursting
behavior when applied to the extracellular side of the membrane (Dudley & Baumgarten,
1993).
In neonatal cardiac myocytes, thyroid hormone (5-20 nM) application doubled the
peak of the inward sodium current with 2 minutes, eventually plateauing at 4 fold control
levels after 4 minutes of hormone application. Sodium current inactivation shifted from
a monoexponential decay to a bi-exponential fit in the same time period. Steady state
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inactivation of sodium current, though, was unaffected by T3 (Harris et al., 1991).
Ca2+ & Glucose Uptake. In rat heart slices, the effect ofT3 (10 pM) on calcium
and glucose uptake was investigated. Thyroid hormone acutely increased calcium (45 Ca)
uptake that was blocked with inorganic calcium channel blockers (La3+, Cd 2+, and Mn 2+)
(Segal, 1990) and increased 2-deoxyglucose uptake, in the presence of cyclohexamide
demonstrating that the effects were independent of new protein synthesis (Segal, 1989).
Segal ( 1990) further demonstrated that the molecular mechanism of action of thyroid
hormone was mediated by calcium as the first messenger for the acute plasma membrane
mediated effects of sugar uptake. In a whole animal experiment, Gmzsche (1994) showed
that acute T 3 administration to a rat resulted in a significant, reversible decrease in
calcium perfusate concentration, which was blocked with the calcium channel blocker,
nifedipine, indicating that the thyroid hormone induced calcium flux into the cell might
be partly mediated through voltage dependent calcium channels.
SR Ca 2+-ATPase Activity.

Thyroid hormone has been found to regulate

sarcoplasmic reticulum membrane Ca2+ -ATPase activity by nonnuclear mechanisms. SR
Ca2+ -ATPase activity determines the rate of calcium reuptake and hence the rate at which
myocardial relaxation occurs. In striated muscle, SR Ca2+ -ATPase activity increased with
T 3 exposure (Warnick et al., 1988).
Calcium Release Channels. Thyroid hormone (250 mM) has also been shown
to increase activation of calcium release channels (ryanodine receptor) in skeletal muscle
SR at the single channel level in planar lipid bilayers (Connelly et al., 1994). The open
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probability (P 0 ) increased significantly in the presence of thyroid hormone. These
researchers demonstrated that T3 produces its effect through a direct activation of the
ryanodine receptor in the absence of other cellular components.
P-adrenergic Receptors. Because the clinical signs of hyperthyroidism mimic

a hyperadrenergic state, the acute effects of thyroid hormone on P-adrenergic receptors
were investigated in cultured chick cardiac myocytes. Initially (under 2 hours), T3 (10
nM) application resulted in an increased number of receptors on the cell membrane, which

was not influenced by the protein synthesis inhibitor cyclohexamide (20 mM). When
colchicine (20 mM) was added to the cultured cells, T3 did not lead to an increase in Preceptor number indicating that the effects of thyroid hormone initially did not depend
upon new protein synthesis but relied on microtubule assembly to promote insertion of
already synthesized receptors into the plasma membrane from the cytosol (Vassey et al.,
1994).
cAMP levels. Levey and Epstein (1968) demonstrated in cat heart homogenates

that thyroid hormone (5xl0-6M) activated adenyl cyclase leading to cAMP accumulation
at levels significantly higher than control animals within 3 minutes.

This cAMP

accumulation was independent of diminished degradation by phosphodiesterase indicating
a direct effect by thyroid hormones on regulating activation of adenyl cyclase. Also since
the effect was produced within 3 minutes, it would suggest that thyroid hormone
increased activity due to actual activation of adenyl cyclase rather than generation of new
enzymes because the time frame appears to be too short for new protein synthesis to

18
occur.
Intracardiac Conduction Time. Shahawy et al. (1975) demonstrated that acute

thyroid hormone exposure in dogs resulted in a decrease in the intracardiac conduction
time. During thyroid hormone perfusion the heart rate increased, the A-H interval
decreased while the H-V interval remained constant when compared with euthyroid
animals. In triiodothyronine treated pigs, cardiac contractility increased significantly after
15 minutes (G0tzsche, 1994). Cardiac output increased along with contractile force
CdP/dt) which was blocked with amiodarone suggesting the mechanism of action of
thyroid hormone was by altering the permeability properties of the calcium channel on
the sarcolemmal membrane (G0tzsche, 1994).
Cardiac Contractility. In an isolated rat heart, Ririe et al. (1995) demonstrated

that a bolus injection of T3 (0. 74 nM) was able to increase left ventricle contractility
CdP/dt) within 30 seconds with no change in end diastolic pressure. T4 was unable to
increase contractility even at levels 17 times (12.9 nM) the bolus injection ofT3 indicating
a specificity for T

3

in mediating the effects of acute hyperthyroidism. The effects of T3

were transient, with the increased contractility dissipating over a period of 60-90 seconds
after drug administration. P-receptor blockade with propranolol (1 mM) did not effect the
ability of T 3 to increase contractility, as maximum developed tension with and without
P-receptor blockade was 393

± 29

and 335

± 38

mmHg/sec, respectively.

T3, at

concentrations that had been shown to increase contractility and even as high as 1o-6 M,
exhibited no effect on cAMP production (Ririe et al., 1995), in contrast to the earlier work
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done by Levey and Epstein ( 1968). At the single cell level, in isolated ventricular
myocytes, T3 caused a dose dependent increase in contractility independent of P-receptor
stimulation (Walker et al., 1994).

Vascular Smooth Muscle.

Hyperthyroidism has been shown to decrease

systemic vascular resistance. Since vascular smooth muscle tonic contraction is a major
determinant of vascular resistance (Berne & Levy, 1993), the acute effects of thyroid
hormone on smooth muscle have been investigated. Thyroid hormone (10-30 mM)
relaxed isolated rabbit mesenteric artery smooth muscle strips previously contracted with
50 mM KCL This relaxation was due to the direct effect of thyroid hormone on vascular
smooth muscle, without influence from endothelium-derived relaxing factor( s), a.- or Preceptor activation, or muscarinic cholinergic receptor activation (Ishikawa et al., 1989).
In cultured smooth muscle cells, addition ofT3 (0.1 nM) produced a visible relaxation of
the cells in 10 minutes (Ojamaa et al., 1994).

CHAPTER III

METHODS

A. Single Cell Isolation Procedure

Adult cats of either sex, weighing approximately 2 kg were anesthetized with
sodium pentabarbitol (80 mg/kg; IP). Single atrial muscle cells were isolated according
to methods previously reported (Wu et al., 1991; Zhou & Lipsius, l 992,93a,b). To
remove the heart a midstemal thoractomy was performed. The heart was quickly attached
to a Langendorff perfusion apparatus at the aorta. The heart was perfused for 5 minutes
with a Tyrode solution at 37°C until the blood was washed out completely (Table 1,
Solution 1). This was followed by a second perfusion of 5 minutes with a Ca2+ -free
Tyrode solution (Table 1, Solution 2) and a final perfusion of 50-60 minutes with a
Tyrode solution containing 36 µM Ca2+, 0.1 % albumin, and 0.06% collagenase (Table 1,
Solution 3). The enzyme solution was recirculated with a pump. During the enzyme
recirculation period, every 10 minutes 27 µM Ca2+ was added to the perfusate to
eventually yield a Ca2+ concentration of approximately 200 µM. The two atria were
removed from the heart and separated from one another by cutting through the sepal
region of the atria. Atrial tissue was cut into small pieces (<0.5 cm2) and incubated in
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fresh enzyme solution for 15 minutes at 37°C while being agitated in a water bath. The
tissue suspension was filtered through a nylon mesh (210 µm) using Tyrode solution
containing 200 µM Ca2+ and 0.1 % albumin. After allowing the cells to settle for around
30 minutes, the superfusate was suctioned off and the isolated cells were gradually
replaced with and stored at room temperature until use in a HEPES-buffered solution
(Table 2, Solution 1).
Cells used for study were transferred to a small tissue bath (0.4 ml) mounted on
the stage of an inverted microscope (Nikon Diaphot) and superfused with a modified
HEPES Tyrode solution (Table 1, Solution 4). Solution was perfused by gravity at
approximately 4 ml/min.

Cells selected for study were elongated, exhibited nice

striations, and were quiescent.

B. Patch-Clamp Recordine Technique
Ruptured patch recording method. Cells used for experiments were transferred

to a tissue bath (0.4 ml) mounted on the stage of an inverted microscope (Nikon Diaphot).
Sodium currents were measured on atrial muscle cells using the ruptured patch whole cell
recording technique (Hamill et al., 1981 ). Pipettes were pulled from borosilicate glass
(Sutter Instrument Co.) in a six step process using a horizontal programmable puller
(Flaming Brown, model PC 80, Sutter Instrument Co.) Pipettes were fire polished to
smooth out the electrode tip by passing current though a platinum wire in close proximity
to the pipette tip. Pipettes were first briefly dipped in the pipette solution to fill the tip
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and the pipette was backfilled with the same solution (Table 3, Solution 1). Pipettes had
internal diameters of 1.0-1.5 µm and when filled with internal solution yielded a final
resistance of 3-4 MQ when placed in the perfusion bath. Capacitance and pipette
resistance were compensated before recording from each cell. Upon touching the cell
membrane, negative pressure was applied to form a gigaseal. After a stable gigaseal was
obtained (2-5 minutes) additional suction was applied to rupture the membrane patch.
Before patch rupture cells were perfused with HEPES Tyrode solution (Table 2, Solution
1). After patch rupture cells were perfuse with a Low Na+ Tyrode solution (Table 2,
Solution 2).
Nystatin-perforated patch recording method. L-type Ca2+ currents and action

potential recordings were measured on atrial muscle cells using the nystatin perforatedpatch whole cell recording technique (Hom & Marty, 1988). Nystatin was dissolved in
dimethylsulfoxide at a concentration of 50 mg/ml and then added to the internal pipette
solution to yield a final concentration of 150 µg/ml. The nystatin containing pipette
solution was strongly sonicated so that the nystatin was completely dispersed in the
solution leaving to pipette solution a clear pale yellow. Pipettes were pulled from
borosilicate glass by a horizontal programmable puller and fire polished. Pipette internal
diameter was 1.0-1.5 µm and when filled with internal solution (Table 3, Solution 2)
yielded a final resistance of2-3 MQ when placed in the perfusion bath. Capacitance and
pipette resistance were compensated before recording from each cell. After the electrode
made contact with the cell surface a slight negative pressure was delivered to form a
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Figure 2
Cellular Patch Clamp Recording Technique

A

B

Ruptl!red patch
techmque

N ys tatin-perforated
patch technique

A. The standard ruptured patch recording technique.
B. The nystatin-perforated patch recording technique.
(modified from Horn & Marty, 1998)
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gigaseal between the cell and the electrode. Before patch attachment, cells were perfused
with HEPES Tyrode solution. After patch seal was established, a High Cs+ Tyrode
solution (Table 2, Solution 3) was used to perfuse the external cell surface at a
temperature of 35°C.

C. Action Potential Recording Method.

Action potentials were elicited by stimulation through the recording electrode in
the bridge mode using 2-3 msec voltage pulses. Pulses were generated by an external
stimulus (Pulsar 4i Stimulator, Frederick Haer & Co.; Brunswick, Maine) and recorded
by computer and magnetic reel to reel tape.

D. Cell Shortening Recording Method.
Video Edge Detector. The cells were superfused with HEPES-Tyrode solution
(Table 2. Solution 1) at 35°C. The nystatin perforated-patch technique was used to gain
access to the cell. A stimulus generated from an external source was applied to the cell
through the cell- attached electrode and the cell shortening produced was measured with
the use of a video edge detector with data stored by the computer and magnetic reel to reel
tape. The spatial resolution of the video edge detector at 400x magnification is 0.015
microns.
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E. Electronic equipment.
Ionic currents (discontinuous single electrode voltage clamp) were recorded in the
ruptured patch whole cell configuration and nystatin perforated-patch whole cell method
with an Axoclamp-2-A amplifier (Axon Instruments, Inc., Foster City, Calif.). Action
potentials were recorded in the bridge mode of the Axoclamp-2-A amplifier. Cells were
externally stimulated through the recording electrode by a Pusar 4i Stimulator (Frederick
Haer & Co., Brunswick, Maine). Cell shortening was measured with a Video Edge
Motion Detector (Cresent Electronics; Sandy, Utah). In the voltage clamp mode the
sampling rate was 10-12 kHz. Computer software run on a Dell 386 (PClamp 6.0
program; Axon Instruments, Inc.) was used to generate the voltage clamp protocols as
well as record and analyze voltage and ionic current signals. Voltage and ionic currents
were sampled by a 12-bit resolution AID converter (Tecmar Labmaster, Tecmar Inc.,
Cleveland, OH) with the use of a Dell 386 computer. Data was stored on hard disc and
backed up on a bemuilli disk for later analysis.

F. Experimental Voltage Protocols.
Na+ Current. Currents were measured using the ruptured patch whole cell
technique (Hamill et al., 1981 ). Ionic currents were activated from atrial cells by
depolarizing clamp steps from a holding potential of -80 mV in 10 mV increments to +50
mV for 80 msec. Two seconds between incremental clamp steps were used to allow from
complete channel recovery from inactivation. Peak Na+ clamp steps were from holding
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potential of -80 mV to -40 mV. Peak Na+ current was measured with respect to steady
state current.
Na+ Channel Steady State Inactivation. Channel kinetics were measured using

the ruptured patch whole cell technique. Cells were held at -120 m V and clamped in 10
mV increments up to +20 mV for 1 second. Following the initial incremental clamp, the
cell was returned to -120 mV for 2 msec, after which the cell was clamped to -40 mV.
Steady State inactivation for each cell was normalized using the maximum peak current
recorded for that particular cell.
Na+ Channel Steady State Activation. Measured using the ruptured patch whole

cell technique. Cells were held at -80 m V and clamped for approximately 2 msec, or a
duration not leading to channel inactivation, in 10 mV voltage steps from -80 to +50 m V.
After the conditioning prepulse to various voltages, the cell was clamped back to -60 m V
and the tail current elicited was measured. Steady state activation was determined by
comparing the tail current elicited at each varying prepulse voltage step with the
maximum current elicited, yielding a normalized steady state activation curve.
Na+ Channel Recovery from Inactivation. Measured using the ruptured patch

whole cell technique. Cells were held at -110 mV and clamped for a conditioning pulse
to -40 mV for 1 second. Following the conditioning pulse was a variable time interval
(from 0.2 msec to 150 msec) at -110 mV after which the cell was clamped to -40 mV for
50 msec. The test current was compared with the conditioning current OtesllconcU at each
recovery time to yield a normalized value for each cell.
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Figure 3
Experimental Voltage Protocols
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Figure 3
Experimental Voltage Protocols
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Ca2+ Current. Ionic currents were measured with nystatin perforated-patch whole
cell recording technique (Hom & Marty, 1988). Cells were held at -40 mV and clamped
from -40 to +70 mV for 200 msec in I 0 mV voltage steps. Peak lea L was measured with
respect to steady state current.

Action Potential and Cell Shortening. Intracellular recordings were obtained
with the nystatin perforated patch technique. Cells were stimulated by an external source
at variable frequencies at a stimulus amplitude sufficient to generate an action potential.
Cell shortening was measure with a video edge detector by following the one edge of the
contracting cell. Action potentials and cell shortening was recording on the computer as
well as magnetic reel to reel tape.

G. Measurements and Data Analysis.
The membrane capacitance (Cm) was measured by delivering a ramp voltage
clamp pulse (dV /dt=5V /sec) and dividing the half-amplitude of the current jump at the
turning point of the ramp pulse by the ramp slope. Whenever possible the currents were
normalized in reference to the Cm of each individual cell to yield current density (pA/pF).
Data are presented as means± standard error of the mean (SEM). Paired t-test was used
for statistical analysis and differences with p values <0.05 were considered statistically
significant.
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H. Solutions. Drugs and Chemical Reagents.
All solutions were made on the same day as the experiment from double-deionized
water. The solutions used for cell isolated are listed in Table 1. The internal pipette
solutions used for standard ruptured patch and nystatin-perforated patch are listed in
Table 3.

List of drugs and chemical reagents:
Collagenase (type II, 209 units/mg)
Albumin (Sigma Chemical Company)
Na2-ATP (grade 1, Sigma Chemical Company)
Ethyleneglycol-bis-N,N,N' ,N' -Tetraacetic Acid (Sigma Chemical Company)
Nystatin (Sigma Chemical Company)
Tetrodotoxin (Calbiochem)
4-Aminopyridine (Sigma Chemical Company)
Tetraethylarnmonium Chloride (Sigma Chemical Company)
Ryanodine (Penick, Lyndhurst, New Jersey)
Verapamil (Sigma Chemical Company)
3,5,3'-Triiodo-L-thyronine (Sigma Chemical Company)
3,3',5'-Triiodo-L-thyronine (Sigma Chemical Company)
3,5,3',5'-Tetraiodothyronine (Sigma Chemical Company)
Thapsigargin (Sigma Chemical Company)
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Table 1.

Cell Isolation Solutions

1
Normal
Tyrode

2
Ca2+-free
Tyrode

3
Perfusion
Enzyme

4
HEP ES
Tyrode

NaCl (mM)

137

137

137

137

KCl (mM)

5.4

5.4

5.4

5.4

CaC12 (mM)

1.8

0.036

1.8

MgC1 2 (mM)

1.0

1.0

1.0

1.0

NaHC0 3 (mM)

12

12

12

NaH2P04 (mM)

0.6

0.6

0.6

Glucose (mM)

11

11

11

Albumin(%)

0.1

Collagenase (%)

0.06

HEPES (mM)
pH

*

11

5
7.4*

7.4*

7.4*

7.35**

Biocarbonate-buffered Tyrode solutions were bubbled with 95% 0 2-5% C02
to pH 7.4.

** Hepes-buffered Tyrode solution was titrated with NaOH to pH 7.35.
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Table 2. Cell Perfusion Solutions

1
HEP ES
Tyrode

2
Low Na+
Tyrode

3
High Cs+
Tyrode

NaCl (mM)

137

50

137

KCl (mM)

5.4

5.4

5.4

CaC1 2 (mM)

2.0

2.0

2.0

MgCl 2 (mM)

1.0

1.0

1.0

TEA-Cl (mM)

67

Verapamil (mM)

0.005

4-Aminopyridine (mM)

2.0

CsCl (mM)

20

20

Glucose (mM)

11

11

11

HEPES (mM)

5

5

5

pH

7.35*

7.35**

7.35*

* Hepes-buffered Tyrode solution was titrated with NaOH to pH 7.35.
** Hepes-buffered Low Na+ Tyrode solution was titrated with CsOH to pH 7.35.
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Table 3. Internal Pipette Solutions

Rupture
Patch (INJ
Glutamic Acid (mM)

2
Nystatin
Perforated
Patch CicJ

100

Cesium Glutamate (mM)

100

Potassium Glutamate (mM)
MgC1 2 (mM)

3
Nystatin
PerforatedPatch (A.P.)

100
1.0

1.0

KCl (mM)

1.0
40

Na2ATP (mM)

4.0

4.0

4.0

EGTA(mM)

10

0.5

0.5

CsCl (mM)

40

40

CsOH (mM)

100

HEPES (mM)

10

10

10

pH

7.20*

7.20*

7.20**

*

Hepes-buffered Low Na+ pipette solution and Ca2+ pipette solution were titrated
with CsOH to pH 7.20.

** Hepes-buffered pipette solution (A.P.) was titrated with KOH to pH 7.20.

CHAPTER IV

RESULTS

To be assured that the Na+ current observed in isolated atrial myocytes were
reasonable, the quality of the voltage clamp was evaluated. To monitor voltage clamp
control two criteria were used. First, the voltage clamp step measured by the electrode
was compared with the voltage clamp step generated by the computer to minimize the
variation. Second, the current generated did not exhibit a "threshold phenomenon" near
the voltage for peak current activation, but rather the current elicited a gradual increase
as the clamp steps approached the peak current level. To aid in controlling the large Na+
current, the [Na] 0 was reduced to 50 mM and all the Na+ current experiments were
conducted at room temperature.

A. Effect of Thyroid Hormone on Na+ Current.
Macroscopic Na+ current was recorded from isolated atrial cells using the ruptured
patch technique. Figure 4A shows the peak inward Na+ current elicited from an atrial
muscle cell during a depolarizing clamp step from -80 mV to -40 mV under control
conditions and when the cell was acutely (5 minutes) perfused with T 3 (10 nM). Under
control conditions the peak inward current was -36.2 pA/pF while after exposure to T3 the
34
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Figure 4
Effect of TJ on Sodium Current in Atrial Myocytes
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Effect of TJ (10 nM) on atrial muscle cells. Panel A
shows the peak inward sodium current elicited from a single
atrial muscle cell in response to an acute exposure of TJ. Panel B
shows the effect of an acute exposure on 25 cells and upon
recovery (R) in 9 cells.
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Figure 4 - continued
Effect of TJ on Sodium Current in Atrial Myocytes
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Panel C shows the effect of T3 (10 nM) on the sodium
current-voltage relationship.
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peak inward Na+ current increased to -42.4 pA/pF. Upon washout of T 3 , the current
decreased to -33.4 pA/pF. In 25 cells tested (Figure 4B) the peak inward Na+ current
increased 26.1 % from -42.9 ± 4.2 pA/pF under euthyroid conditions to -54.1

± 4. 7 pA/pF

after an acute exposure to T3 • In 9 cells, after washout of 1; for S minutes, the current
returned to -4S.4 ± 4.3 pA/pF indicating that T3 was able to be virtually removed from the
plasma membrane receptors or that by this time in the experiment (2S minutes) the cell
had deteriorated such that the Na+ current had rundown more even with T3 still bound to
its receptors.
When the current-voltage relationship (Figure 4C), generated by 10 m V
incremental clamp steps from -80 mV to +SO mV (Figure 3A), was investigated in 7 cells,
the onset of inward current (-60 mV), the voltage generating maximal inward current (-40
m V) and the reversal potential (+41. 7 mV) all showed no variation between control
conditions and when T 3 was applied. The Na+ current showed an apparent reversal
potential of +41. 7 ± l .S mV, close to the ~eoretical reversal potential value of +46. 7 m V
calculated using the Nerst equation for a channel strictly passing Na+ current, giving
indication that the current elicited was the Na+ current.
To investigate whether the increase in peak inward Na+ current was specific to T3
or showed similar responses to the other hormones produced by the thyroid gland, rT3 and
T 4 were investigated. Figure SA shows the current elicited in a single clamp step from
-80 mV to -40 mV in an atrial muscle cell in response to exposure to rT3 (10 nM). In
3 cells tested (Figure SB), the peak inward Na+ current showed no statistically significant
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Figure 5
Effect of rT3 on Peak Inward Sodium Current
in Atrial M yocytes
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Effect of rTJ (10 nM) on atrial muscle cells. Panel A
shows the effect on the peak inward sodium current upon exposure
to rT3 in a single atrial muscle cell. Panel B summarizes the effect
of rT3 on the peak inward sodium current in 3 cells.
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Figure 5 - continued
Effect of rT3 on Sodium Current
in Atrial Myocytes
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current-voltage relationship.

40

Figure 6
Effect of T4 on Peak Inward Sodium Current
in Atrial Myocytes
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Effect of T4 (10 nM) on atrial muscle cells. Panel A
shows the effect on the peak inward sodium current upon exposure
to T4 in a single atrial muscle cell. Panel B summarizes the effect
of T4 on the peak inward sodium current in 3 cells.
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Figure 6 - continued
Effect of T4 on Sodium Current
in Atrial Myocytes
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Panel C shows the effect of T4 (10 nM) on the sodium
current-voltage relationship.
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variation between control (-60.9 ± 1.6 pA/pF) and rT3 (-59.7 ± 2.2 pA/pF). The currentvoltage relationship (Figure SC) corroborated the peak current data, further demonstrating
that rT3 did not alter the threshold for channel activation, the voltage of peak current
generation, or the reversal potential, indicating in our experiment design rT3 failed to
produce effects similar to T 3 • Likewise, the effects of T 4 on atrial Na+ current were
investigated. As shown in figure 6A & 6B, the peak inward Na+ current exhibited no
significant change with T4 (control: -58.2 ± 2.0 pA/pF vs. T 4 : -55.7 ± 2.2 pA/pF).
Similarly the current-voltage relationship (Figure 6C) did not vary with T4 application,
in its onset of current activation, its voltage of peak current or its reversal potential,
giving indication that the increase in Na+ current was specific to T3 •
To demonstrate that the current being elicited from the voltage clamp protocol was
the "fast" Na+ current, TIX (tetrodotoxin) along with variations in the holding potential
of the cell were employed. Figure 7A demonstrates that 10 µM TTX was able to block
95.6% of the current as compared to control conditions (-2.2 ± 0.8 pA/pF vs. -47.9 ± 5.8
pA/pF). In figure 7B the holding potential of the atrial muscle cell was varied from -80
mV (HP-80) to -40 mV (a level believed to inactivate the sodium current). When the cell
was clamped from these holding potentials to 0 mV the current generated at HP-80, -8.4

± 0.6 pA/pF, was nearly completely eliminated at

HP-40, -0.11

± 0.05 pA/pF.

These two

results suggest that the current elicited by the voltage protocol is strictly the "fast" Na+
current.
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Figure 7
Effect of TTX on the Sodium Current
in Atrial Myocytes
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Demonstration that the current elicited from the voltage
clamp protocol (Figure 3A) is the "fast" sodium current. Panel A
shows the effect of TIX (10 uM) on the current-voltage
relationship. Panel B shows the effect of varying the holding
potential (HP) of the cell on a single clamp step from HP to 0 mV.
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B. Effect of T3 on Na+ Channel Kinetics.
To uncover the possible mechanism responsible for the increase in Na+ current,
channel kinetics were investigated. The steady state properties of Na+ current inactivation
were studied using a standard two-pulse protocol (Figure 3B). First a step of variable
amplitude and a duration long enough to activate the Na+ current were applied. Atrial
cells were clamped from prepulses to selected conditioning potentials from a holding
potential of -120 mV positive to +20 mV. After repolarization to the holding potential
for 2 msec, a test pulse to -40 mV was applied. The current elicited by the test pulse was
normalized to that obtained in the absence of a preceding conditioning pulse and
compared in the presence and absence ofT3 •
The steady state properties of Na+ current activation were studied by measuring
tail currents (Figure 3C). The atrial cell membrane was depolarized from -80 m V to a
conditioning potential for a time long enough to allow the activation process to obtain its
steady state value. The duration of the conditioning clamp was short enough so that
inactivation did not have time to develop. At the end of the conditioning pulse the
membrane was clamped to a fixed test potential and the amplitude of the tail current at
the beginning of this step was measured. Atrial cells were held at -80 m V and clamped
for approximately 2 msec, or a clamp duration not leading to channel inactivation, in I 0
m V voltage steps to +50 mV. After the conditioning prepulse to various voltages, the cell
was clamped back to -60 mV and the tail current was measured. Steady state activation
was determined by comparing the tail current elicited at each varying prepulse with the
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maximum current elicited, yielding a normalized steady state activation curve.
Figure 8A shows inactivation/activation curves in the absence and presence of T3
(10 nM). In 10 cells tested there was no statistically significant increase in either
parameter with T3 • Data were fitted by curves calculated using the Boltzmann function
: I/Imax = {1 + exp[(Vc-V 0 _5 )/k]}· 1, where Ve is the voltage of the conditioning pulse, V0 .5
is half maximal voltage, and k is the slope factor. At -110 mV, h"' was 0.994 ± 0.006; at
-40 it was 0.002

± 0.005.

The voltage of half-activation was -83.5 mV in control

conditions versus -82.5 mV in the presence of T3 • The slope factor, k, was 7.1 under
control and T3 conditions. Under control and T3 conditions, steady state activation had
an initial onset of -60 mV and reached a peak channel activation at -20 mV. The
"window" current, which is considered to be the steady state component of the "fast" Na+
current resulting from the crossover of the activation and inactivation curves which
govern the opening of the Na+ channel, did not change with T3 exposure.
The time course of Na+ current recovery from inactivation was defined using the
two-pulse protocol shown in figure 3D. Cells were held at -110 mV and clamped for a
1 second conditioning pulse to -40 mV. Following the conditioning pulse was a variable
time interval (from 0.2 msec to 150 msec) at the holding potential after which the cell was
clamped to -40 m V for 50 msec. The test current was compared with the conditioning
current OtesllcomJ at each recovery time. Na+ channel recovery from inactivation (Figure
8B) was investigated in 6 cells. There was no statistical variation in channel recovery rate
in the absence or presence of T3 • In both cases the channel reached 90% recovery in
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Figure 8
Effect of TJ on Sodium Channel Kinetics
in Atrial Myocytes
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Figure 8 - continued
Sodium Channel Recovery from Inactivation
in Atrial M yocytes
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approximately 25 msec.

C. Effect of T3 on Ca2+ current.
Other researchers have documented a chronic increase in the L-type Ca2+ channel
current in the presence of thyroid hormone (Binah et al., 1987) as well as an acute
increase in calcium uptake (Gmzsche, 1994; Segal, 1989). In this experimental design,
in the time demonstrated to increase the Na+ current (0-15 minutes) there was no increase
in the peak Ca2+ current (Figure 9A) or in the current-voltage relationship (Figure 9B).
In 7 atrial muscle cells tested the onset of the current, the voltage of peak current, and the
reversal potential of the current all remained unchanged when comparing control and T 3

(IO nM).
The T-type Ca2+ current may be influencing the increase seen with T3 when
measuring the Na+ current. To investigate this possibility, NiC1 2 (50 µM), a specific
blocker of the T-type Ca2+ current (Wu & Lipsius, 1990) was perfused. Initially the cell
was exposed to T 3 and the voltage protocol used to measure the Na+ current (Figure 3A)
was employed. After an increase in Na+ current was seen with T 3 , Ni Cl 2 + T3 was
perfused and the current was recorded. In 5 atrial cell after 5 minutes of perfusion with
NiC1 2 there was no statistically significant decrease in the peak inward Na+ current (Figure
9C) (Control: -45.9 ± 2.3 pA/pF, T 3 : -55.2 ± 3.8 pA/pF, T 3 + NiC12 : -52.9 ± 3.0 pA/pF).
These results indicate that the T-type Ca2+ current was not influencing the increase seen
in the Na+ current with exposure to T 3 •
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Figure 9
Effect of T3 on L-type Calcium Current
in Atrial M yocytes
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Effect of TJ (10 nM) on the L-type calcium current in
atrial muscle cells. Panel A shows the peak inward calcium
current in control, TJ, and recovery. Panel B shows the
current-voltage relationship for the L-type calcium current
under control conditions and after acute TJ exposure.
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Figure 9 - continued
Influence of T-type Calcium Current on
Sodium Current Increase with T3
in Atrial Myocytes
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and after recovery.
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D. Effect of T 3 on Action Potential Properties.
Correlating the changes seen in the Na+ current data, stimulated (0.5 Hz) atrial
muscle cell action potentials were investigated. In figure 1OA & B the effect of T3 on
action potentials in a single atrial muscle cell at room temperature were investigated.
Exposure to T3 ( 10 nM) lead to a gradual "notching" of the plateau phase of the action
potential, in 3 of 5 cells tested. Upon withdrawal of T3 , in all 3 cells, this "notching"
disappeared. The resting membrane potential and peak action potential overshoot were
unaffected by T3 exposure. Action potential duration (90% repolarization) decreased with
T 3 exposure from 525.4 ± 7.0 msec to 479.2

± 9.0 msec. Interestingly the duration of

50% repolarization slightly increased with T3 from 233.6 ± 8.0 msec to 248.4 ± 10.4 msec
due probably to the "notching" seen during the plateau phase of the action potential.
Figure 11 shows the effects of T3 on stimulated (0.5 Hz) atrial muscle cells at
35°C. Exposure to T 3 (10 nM) lead to spontaneous depolarizations which increased in
frequency with the length of the T3 perfusion. In 7 out 10 cells tested, perfusion with T3
lead to the generation of spontaneous beats. Of the cells that exhibited spontaneous beats,
the average time before spontaneous beats developed was 4.9 ± 0.9 minutes with a range
from 1 to 8 minutes. After 5 minutes of perfusion at 35°C, the cells exhibited on average
10.4 ± 1.4 extra beats in a 40 second period. Upon withdrawal ofT3 in 5 out of 7 of these
cells the spontaneous beats disappeared.
In two series of experiments, the effect of SR load was investigated to determine
its effect on the T3 induced delayed after depolarizations. Ryanodine, an alkaloid that
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Figure 10
Effect of T3 on Atrial Action Potential
@ Room Temperature
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Action potential recordings from an atrial muscle cell
stimulated at 0.5 Hz at room temperature. Recordings during
control, TJ (10 nM), and recovery.
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Figure 10 - continued
Effect of T3 on Atrial Action Potential
@ Room Temperature
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Panel B shows individual action potentials in atrial
muscle cells stimulated at 0.5 Hz at room temperature.
Recordings during control, TJ (10 nM), and recovery.
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Figure 11
Effect of T 3 on Atrial Action Potential
@35° c
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opens SR Ca2+ release channels (Janczeski & Lakatta, 1993) and prevents accumulation
of SR Ca2+ and thapsigargin, an inhibitor of SR Ca2+ uptake (Rousseau et al., 1987) were
tested. Figure 12 shows that the effects of ryanodine on stimulated atrial muscle cells in
the presence ofT3• In 4 atrial cells demonstrating spontaneous beats with T 3 , ryanodine
(I µM) in the presence of T 3 lead to the elimination of the extra beats. Similarly,
thapsigargin (5 µM) also eliminated the extra beats in the presence of T 3 alone (data not
shown). During control conditions, resting membrane potential was -56.4 ± 0.5 mV as
compared to -55.0

± 0.7 mV when perfused with T 3• Likewise the action potential

overshoot showed no statistically significant variation with T3 (control: 23.6 ± 0.2 mV vs.
T 3 : 25.5 ± 1.7 mV). These results indicate that by inhibiting the accumulation of SR Ca2+,
these agents selectively abolished the proarrhythmic effects of T 3 •

E. Effect of T 3 on Cell Shortening
Finally the contractile behavior of single atrial cells was investigated (Figure 13).
Cell contractile strength was quantified by measuring unloaded cell shortening in
response to a stimulus sufficient to generate an action potential. A video edge detector
was used to track the edge of one edge of the cell to quantify the degree of cell shortening.
Figure 13 depicts simultaneous action potential recordings (A) and cell shortening (B)
under control, T 3 , and recovery conditions. In 5 atrial muscle cells the cell shortening
increased 34.8 ± 1.6 % when T 3 was perfused as compared with control. Upon washout
of T 3 for 5 minutes, contractility returned to cell shortening 8.4 ± 1.1 % above control
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Figure 12
Effect of Ryanodine on Action Potentials
in Atrial Myocytes
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Influence of SR load on TJ (10 nM) induced arrhythmias.
Action potentials were recorded from atrial muscle cells at 35 ° C,
under control, TJ, and after TJ + Ryanodine (1 uM). Spontaneous
beats are indicated by the (*).

Figure 13
Effect of TJ on Action Potentials and Cell Shortening in Atrial Myocytes
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levels indicating that T3 still had lingering effects due probably to slow dissociation of T3
from the plasma membrane receptors.

CHAPTERV

DISCUSSION

The main purpose of the present study was to determine the acute (0-15 minute)
effects of thyroid hormone (T3) on atrial muscle cells. Cardiac muscle cells were isolated
from the cat atrium and the properties of the Na+ current, the Ca 2+ current, action
potentials and cell shortening generated by stimuli were investigated in the presence of
thyroid hormone (T3). Investigation into an individual ionic current was accomplished
by isolation of a particular current through a specific voltage clamp protocol and by
blocking currents other than the one of interest by use of specific channel blocking agents
(i.e. 4-aminopyridine, verapamil, Ni2+). Na+ current was measured by the ruptured patch
whole cell recording technique to decrease access resistance to the cell while Ca2+ current
and action potential recordings were measured with the nystatin-perforated patch
technique to minimize cell dialysis of intracellular constituents with the internal pipette
solution and to decrease current rundown.
In these experiments, T3 at a dose ( 10 nM) comparable with research conducted
by other investigators was perfused around the isolated cells to produce the acute
hyperthyroid state. In humans the normal circulating serum thyroid hormone (T3) levels
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are in the nanomolar range (2.33 ± 0.54 nM), and patients experience the clinical signs
of hyperthyroidism at slightly higher levels (5.08 ± 1.60 nM)(Gall0e et al., 1993). With
the biologically active free T 3 levels only 0.2-0.3% of the serum levels (Berne & Levy,
1993 ), the use of 10 nM in our experiments might at first seem like a high hormone
concentration. A number of things must be kept in mind.
First, we are investigating the effects of thyroid hormone in vitro and not in vivo.
There could be other mitigating factors not present in our system which are present in the
intact animal (human) where by levels of thyroid hormone near the cell surface might be
much greater than blood levels detected by common clinical procedures. In chronic
thyroid hormone experiments, researcher have shown a preferential uptake of thyroid
hormone into the cell, indicating that the cell can create a concentration gradient with
higher concentrations of thyroid hormone inside the cell than outside in the bathing
medium (De Nayer, 1989; Pontecorvi & Robbins, 1986; Krenning et al., 1981;
Oppenheimer & Schwartz, 1985). Therefore, it is not unreasonable to believe that T 3
bound to the plasma membrane receptors may be at a higher concentration than the free
circulating levels in the blood.

To date there is no known study looking at the

concentration of thyroid hormone bound to the plasma membrane surface in relation to
the concentration measured in the blood.
Second, thyroid hormone has been shown to bind to various plastics (Sypniewski,
1993). Since the perfusion apparatus and tubing leading to the cell bath are made from
plastic solution reservoirs and polyethylene tubing (PE tubing), it may be possible that
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the actual concentration of thyroid hormone at the cell surface might be lower than the
concentration of thyroid hormone in the stock perfusion solution.
Third, the cell isolation procedure may have disrupted at portion of the thyroid
hormone plasma membrane receptors, requiring a higher concentration of T3 to cause
anoticeable effect on the Na+ current than would have been needed with the full
compliment of plasma membrane receptors. Segal and Ing bar (1986) have shown that
trypsinization of the membrane can remove the functionality of the plasma membrane
receptors. They demonstrated that trypsinization caused attenuation of binding and action
of T 3 on the plasma membrane in rat myocytes. So it could be possible that the cell
isolation procedure caused a disruption in the normal binding of T3 with its plasma
membrane receptors, requiring an increased concentration of T3 to lead to a functional
change upon binding to the plasma membrane receptors. Also, since the extracellular Na+
concentration was reduced by

1
/ 3,

to decrease the magnitude of the Na+ current so the

electrode could follow the voltage clamp step, the concentration of T3 required to show
a significant effect on the Na+ current might need to be higher than during in vivo
condition when the [Na]0 is the typical 13 7 mM.
Characteristically, the plasma membrane-mediated effects of thyroid hormone are
prompt in onset (seconds to minutes), thereby being independent of influencing new
protein synthesis/degradation rates, and are associated with changes in the transmembrane
transport of ions and substrates (Segal, 1989). In chronic hyperthyroidism, thyroid
hormone binds to nuclear thyroid hormone receptors (c-erb A) altering gene
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transcription, leading to changes in protein synthesis/degradation rates. Shanker et al.
( 1987), investigating the response of individual mRNAs to T3 , showed that in all but one
translational product responsive to T3 (n=13), the time require for induction was on the
order of at least a couple of hours. In the translational product demonstrating the most
rapid response to T 3 , "spot 72b", within one hour of T 3 exposure, levels rose to 2.6 fold
those of control. Oppenheimer demonstrated that this lag time between thyroid hormone
application and response in mRNA levels was as short as 20 minutes for the appearance
of the cytoplasmic mRNA for the protein termed "spot 14" (Oppenheimer, 1985). Still,
one must remember that formation of mRNA is just one of the first few steps of protein
synthesis. Before this up regulated mRNA level leads to an up regulated protein level
affecting cell functional properties, protein translation, modification, translocation and
possible membrane insertion must take place, all requiring additional time.
Further support for the action of T3 not mediating its effects through a nuclear
mechanism in our experimental design, comes from research conducted by Banerjee et

al. (1988), who showed that nuclear receptors for thyroid hormone are lower in atrial
tissue versus ventricular tissue. They showed that the binding capacity for T 3 nuclear
receptors in the atrium was considerably lower than found in the ventricle. Maximum
binding capacity was 170 ± 20 fmol/mg DNA for ventricular nuclei vs. 55
DNA for atrial muscle cell nuclei (Banerjee et al., 1988).

± 10 fmol/mg

In our experiments,

cyclohexamide was not used to block protein synthesis, but due to the short time interval
(under 15 minutes and in most cases under 10 minutes) between initial exposure to T3 and
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measurable effect on Na+ current as well as the lower nuclear T3 receptor number in atrial
versus ventricular tissue, we are confident that the increase in the Na+ current is not
working through nuclear receptors up regulating protein synthesis rates but rather through
a plasma membrane mediated mechanism.
In the present experiments thyroid hormone (T3) was shown to acutely increase
the Na+ current in atrial myocytes. Using the ruptured patch technique which dialyses the
cell with the internal pipette solution, Na+ current increased (26.1%) within 10-15
minutes. In 11 control cells, the Na+ current ran down less than 10% (-44.3

± 4.5 pA/pF

to -39.8 ± 4.1 pA/pF) over the time demonstrated to increase Na+ current with T3 in other
cells. Therefore, in actuality the Na+ current increase with T3 is really an underestimate
of the true magnitude of the effect of T3 on INa. Other groups have shown a similar
increase in macroscopic Na+ current in neonatal myocytes (Craelius et al., 1989) and an
increase in single Na+ channel bursting behavior in ventricular myocytes (Dudley and
Baumgarten, 1993) with T3 exposure. Upon washout ofT3 , in 9 cells tested, Na+ current
returned to levels slightly above initial control levels, indicating either that T3 was able
to be removed from the plasma membrane receptors of the cells or that by this time
(around 25 minutes) into the experiment the cells were deteriorating at a rate sufficient
to decrease the magnitude of the Na+ current.
The acute increase in Na+ current was shown to be specific to T3 as T4 and rT3 ,
other hormones produced by the thyroid gland, exhibited no effect on the Na+ current. In
experiments similar to these, Sakaguchi et al. ( 1995) demonstrated that T 3 acutely
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increased the inward rectifier potassium current (IK 1) but rT3 did not potentiate the IK 1
current, even partially inhibiting the effect ofT3 on increasing IKt· In contrast with our
results, other researchers have demonstrated an effect of T4 on isolated cardiac cells on
the expression of SR mRNA protein (Arai et al., 1991), Na+-Ca2+ exchanger expression
(Boerth & Artman, 1996) and cardiac conduction (Shahawy et al., 1975) though primarily
the effect was seen in chronic T4 exposure where peripheral conversion, by 5'monodeiodinase, could still occur from T4 to T3 •
To investigate the mechanism by which T3 is generating an increase in the Na+
current, Na+ channel kinetics were investigated. Both the steady state activation and
steady state inactivation curves did not change with T3 indicating that there was no
alteration in the gating mechanism of the channel with T 3 • In an individual isolated
current, the decay of the peak Na+ current showed similar kinetics as control. In contrast
to these findings, Craelius et al. (1989), found the decay from peak Na+ current slowed
with an acute T3 exposure. In our findings the recovery of the channel from inactivation
showed no difference with T3 • Because the ruptured patch technique of cellular recording
was used, cellular constituents in the cytoplasm were dialyzed away removing their
potential influence on the gating mechanism of the channel. But since the increase in Na+
current was also demonstrated with the rupture patch technique, the lack of cellular
constituents did not influence the effect ofT3 on increasing the Na+ current indicating that
a cytosolic second messenger is probably not involved in the upregulation of the Na+
current with T3 • The lack of alterations in the sodium channel kinetics with T3 indicate
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that T 3 is not altering the voltage sensor of the channel or the ability of the channel to
recover from the inactivated state.
For the macroscopic Na+ current to increase, the number of functional Na+
channels (N) could increase, the open probability of an individual channel (P0 ) could
increase, or the current(/) passing through an individual channel could increase. The
proposed mechanism by which T3 is increasing the macroscopic Na+ current is by
increasing the open probability of the channel. Previously, in single channel recordings,
Dudley and Baumgarten (1993) showed in ventricular tissue that single channel current
did not increase with T3 but rather there was an increase in the bursting behavior of the
channel. This does not discount the chance that T3 may also be increasing the number of
functional Na+ channels, but due to the time frame (minutes) associated between
application of T3 and the measured cellular response, it seems unlikely that new channels
are inserted into the membrane at such a fast rate.
It could be possible that T3 is acting to "turn on" Na+ channels already in the

plasma membrane and thereby increasing the macroscopic current. Sen & Cui (1992)
showed in ventricular myocytes that T3 (lxI0- 8M) acutely increased the TTX-sensitive

INa· When GTP was loaded into the cells, the onset of increase in INa with T3 occurred
sooner and lead to a greater increase in the peak Na+ current level. This effect was
abolished when the cells were pretreated with pertussis toxin, giving indication that PTX
sensitive G proteins may play an important role in the molecular mechanism underlying
the regulation of Na+ channels by T3 • Therefore T3 may be acting through membrane-
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delimited PTX sensitive G proteins (Wickman & Clapham, 1995) to activate Na+
channels, leading to an increased macroscopic Na+ current.
Segal and Gmzche showed that T3 acutely increased calcium uptake into the cell.
Segal ( 1989) demonstrated that thyroid hormone acutely increased calcium (4 5Ca2 +)
uptake in thymocytes that was blocked with inorganic calcium channel blockers, while
Gmzche (1994) showed in a whole animal experiment that T3 decreased calcium perfusate
concentration (i.e. increased cellular calcium uptake) which was blocked with the calcium
channel blocker, nifedipine. In chronic hyperthyroidism Binah et al. (1987) showed that
peak Ca2+ current increased in ventricular myocytes. In contrast with these results, in
atrial myocytes T 3 failed to elicit a different response in the Ca2+ current than under
control conditions. In the time demonstrated to increase the Na+ current (0-15 minutes)
there was no increase in the Ca2+current peak amplitude, nor a shift in the current-voltage
relationship of the channel in response to T3 , indicating that the cellular effects of T3 in
these experiments were not influenced by changes in the L-type Ca2+ current.
The T-type Ca2+ current could also be influence by T3 • To investigate this
possibility, recordings were performed on cells in the presence and absence ofNi2+ (50
µM), a specific blocker of the T-type Ca2+ current (Wu & Lipsius, 1990). The increase
in Na+ current demonstrated with T 3 was not decreased by perfusion of the cell with T3
and Ni 2+ giving indication that the T-type Ca2+ current was not involved in the acute
cellular response to T3 • Even ifthe T-type Ca2+ current influenced the current increase
with T3 , because the T-type Ca2+ current is so small in atrial myocytes, -1.0 ± 0.06 pA/pF
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(Wu & Lipsius, 1990), the T-type Ca2+current would have to increase at least 5-6 fold to
account for the approximately 10 pA/pF increase (-42.9 to -54.l pA/pF) seen in the
current with T3 •
Correlating the cellular changes in the macroscopic Na+ current with the functional
properties of cardiac muscle cells, the effects of T3 on atrial muscle cell action potential
and contractile strength were investigated. At room temperature, acute T3 exposure
caused a decrease in the action potential duration. The plateau phase of the action
potential exhibited a "notching" effect indicating a secondary increase in net inward
current generated. Typically during the plateau phase of the action potential current
influx is equal to current outflux, hence generating the plateau in the voltage recording.
Sharp et al. (1985) showed a similar phenomenon of "double spikes" in the action
potential recordings in the presence of chronic hyperthyroidism which was eliminated by
the calcium channel blocker D-600, suggesting that the current responsible for this second
depolarization was mediated by a voltage dependent Ca2+ conductance. The current
responsible for "notching" seen in our experiments was not fully investigated but thoughts
are that it may be an increased Ca2+ influx through the Na+ -Ca2+ exchanger.
When the same atrial cells were raised to 35°C, this "notching" was no longer
observable, probably due to the faster cellular repolarization at 35°C. Instead the cells
developed spontaneous depolarizations between the stimulated beats. As the length of
the perfusion with T3 increased the frequency of the spontaneous beats also increased.
When T3 was removed from the perfusion solution, these spontaneous beats disappeared.
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To investigated the mechanism responsible for the development of the spontaneous beats,
ryanodine and thapsigargin were perfused along with T3 • Ryanodine and thapsigargin are
both pharmacological compounds which inhibit the SR from accumulating Ca2+, thereby
preventing SR Ca2+ load (Janczewski & Lakatta, 1993; Rousseau et al., 1987).
Ryanodine (1 µM) and thapsigargin (5 µM), when perfused with T 3 in cells exhibiting
spontaneous beats with T 3 alone, eliminated the arrhythmogenic effects ofT3 • Therefore,
these results imply that the spontaneous beats associated with T3 application resulted from
an increase in SR Ca2+ load. Kass et al. (1977) detailed evidence consistent with the idea
that an oscillatory release of Ca2+ from internal stores is the primary event underlying
development of aftercontractions (i.e. early after depolarization and delayed after
depolarizations).

As the SR gradually increased its Ca2+ load with T 3 application,

occasional spontaneous releases of Ca2+ from the SR occurred leading at first to
spontaneous subthreshold contractions, eventually leading to the generation of full
spontaneous action potentials. Upon washout of T3, as the SR Ca2+ load returned to
normal levels, these spontaneous contractions subsided.
Finally the contractile behavior of isolated atrial cells were investigated.
Contractility was quantified by measuring cell shortening in response to a stimulus
sufficient to elicit an action potential. Upon the addition of T 3, within 15 minutes
contractility increase 34.8 ± 1.6 %. Similar increases in tension/contractile development
have been seen with acute T 3 exposure in experiments ranging from isolated muscle cells
(Snow et al., 1992, Mager et al., 1992), to the isolated perfused heart (Tielens et al.,

69
1996), to the intact animal (Getzsche, 1994). Contractility is believed to increase with
increased total cytosolic [Ca2+] (Bers, 1991). Therefore, if more Ca2+ is released from the
SR during each stimulus due to a greater Ca2+ load, a larger contraction will develop.

SUMMARY

These results support clinical findings seen in chronically hyperthyroid patients
who traditionally present themselves with classic symptoms of increased heart rate, stroke
volume, cardiac output and cardiac contractility along with potential atrial irregularities
including atrial fibrillation (Klein & Ojamaa, 1994; Ridgeway, 1994; Natazawa et al.,
1994). The present experiments suggest the possible cellular mechanism responsible for
the development of some of these symptoms originates from an increased Na+ influx
through the TTX-sensitive "fast" Na+ channel.

These results demonstrate that T3

increases intracellular Na+ concentration by increasing influx through the TTX-sensitive
"fast" Na+ channels. The L-type Ca2+ current was not shown to increase in response to
an acute exposure ofT3• In previous work, T 3 was shown to increase the Na/Ca exchange
current (INa1ca) (Wang & Lipsius unpublished result). Therefore the rise in intracellular
Na+, through the TIX-sensitive Na+ channel, is believed to stimulate Na/Ca exchange to
raise intracellular Ca2+ concentration. This elevation in intracellular Ca2+ loads the
sarcoplasmic reticulum (SR) with Ca2+. With this augmentation in cellular calcium load,
contractility increases as more calcium is released from internal stores during each
stimulated beat. Overload of the SR with Ca2+has been shown to lead to the development
of Ca2+-mediated delayed after depolarizations and spontaneous activity (Kass et al.,
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